Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/CSJ stock hub

FRA/CSJ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/CSJis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35.8B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/CSJ

In the news

Latest news · FRA/CSJ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E30.1

P25 n/aP50 n/aP75 n/a

ROE6.7

P25 n/aP50 n/aP75 n/a

ROIC11.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/CSJ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

USD

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	DE
Employees	29,904
Employees Change	-2,794%
Employees Change Percent	-8.54
Enterprise value	EUR 46.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 35.8B
Price	EUR 73.01
Price currency	EUR
Rev Per Employee	438,808.92x
Sic	2836
Symbol	fra/CSJ
Website	https://www.csl.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.32%
EV Earnings	39.25x
EV/EBIT	12.59x
EV/EBITDA	10.23x
EV/FCF	17.97x
EV/Sales	3.28x
FCF yield	7.26%
P/B ratio	2.05x
P/E ratio	30.1x
P/S ratio	2.73x
PE Ratio10 Y	37.13x
PE Ratio3 Y	31.08x
PE Ratio5 Y	32.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.08%
EBITDA Margin	31.41%
FCF margin	19.8%
Gross margin	51.87%
Gross Profit	EUR 6.8B
Gross Profit Growth	-1.08%
Gross Profit Growth Q	-1.91%
Gross Profit Growth3 Y	1.23%
Gross Profit Growth5 Y	2.7%
Net Income	EUR 1.2B
Net Income Growth	-49.2%
Net Income Growth Q	-80.02%
Net Income Growth3 Y	-19.16%
Net Income Growth5 Y	-8.65%
Pretax Margin	10.15%
Profit Margin	9.06%
Profit Per Employee	EUR 39,760
ROA	6.58
Roa5y	7.85
ROCE	12.07
ROE	6.66
Roe5y	19.06
ROIC	11.52
Roic5y	15.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.91%
Cagr15y	9.15%
Cagr1y	-45.27%
Cagr20y	11.4%
Cagr3y	-25.21%
Cagr5y	-14.86%
Div CAGR10	8.31%
Div CAGR3	3.71%
Div CAGR5	6.84%
EPS Growth	-49.48
EPS Growth Q	-80.15
EPS Growth3 Y	-19.33
EPS Growth5 Y	-8.78
FCF Growth	38.39%
FCF Growth Q	14.19%
FCF Growth3 Y	16.74%
FCF Growth5 Y	17.31%
OCF Growth	22%
OCF Growth Q	3.42%
OCF Growth10 Y	0.09%
OCF Growth3 Y	9.25%
OCF Growth5 Y	6.74%
Revenue Growth	1.16x
Revenue Growth Q	-1.78x
Revenue Growth3 Y	1.35x
Revenue Growth5 Y	2.97x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.4
Assets	EUR 32.3B
Cash	EUR 975.2M
Current Assets	EUR 10B
Current Liabilities	EUR 3.9B
Debt	EUR 9.5B
Debt EBITDA	EUR 2.25
Debt Equity	EUR 0.54
Debt FCF	EUR 3.65
Equity	EUR 17.4B
Interest Coverage	9.54
Liabilities	EUR 14.9B
Long Term Assets	EUR 22.2B
Long Term Liabilities	EUR 10.9B
Net Cash	EUR -8.5B
Net Cash By Market Cap	EUR -23.78
Net Debt EBITDA	EUR 2.06
Net Debt Equity	EUR 0.49
Net Debt FCF	EUR 3.28
Tangible Book Value	EUR 3B
Tangible Book Value Per Share	EUR 6.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	1.17
Net Working Capital	EUR 5.8B
Quick ratio	1.15
Working Capital	EUR 6.2B
Working Capital Turnover	EUR 2.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.1%
Dividend Growth	-1.46%
Dividend Growth Years	8%
Dividend per share	EUR 2.47
Dividend Years	28
Dividend Yield	3.36%
Ex Div Date	2026-03-10
Last Dividend	EUR 1.1
Payout Frequency	Semi-Annual
Payout Ratio	101.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	20.87%
1Y total return	-45.25%
200-day SMA	104.4
3Y total return	-58.17%
50-day SMA	82.97
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.27%
All Time High	212.9
All Time High Change	-65.71%
All Time High Date	2020-02-19
All Time Low	2.14
All Time Low Change	3,306.91%
All Time Low Date	2003-05-28
ATR	1.76
Ch YTD	-25.64
High	73.56
High52	153.1
High52 Date	2025-07-31
High52ch	-52.3%
Low	73.01
Low52	73.01
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-12%
Price vs 200-day SMA	-30.08%
RSI	31.14
RSI Monthly	26.04
RSI Weekly	25.56
Sharpe ratio	-1.69x
Sortino ratio	-1.82
Total Return	3.26%
Tr YTD	-24.69
Tr15y	272.06%
Tr1m	-12.86%
Tr1w	-2.99%
Tr3m	-30.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.4B
Operating Income Growth	-2.1
Operating Income Growth Q	-3.16
Operating Income Growth3 Y	1.03
Operating Income Growth5 Y	3.26
Operating margin	26.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	485,008,433%
Net Borrowing	-831,002,760
Shares Insiders	0.06%
Shares Institutions	36.99%
Shares Qo Q	-0.05%
Shares Yo Y	0.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2.5B
Average Volume	48.8x
Bv Per Share	32.96
CAPEX	EUR -471.8M
Ch10y	4.95
Ch15y	192.4
Ch1m	-12.86
Ch1w	-2.99
Ch1y	-46.56
Ch20y	520.8
Ch3m	-31.63
Ch3y	-60.35
Ch5y	-58.53
Ch6m	-26.56
Change	-3.93%
Change From Open	-0.75
Close	76
Days Gap	-3.21
Depreciation Amortization	697,024,764
Earnings Date	2026-08-18
EBIT	EUR 3.4B
EBITDA	EUR 4.1B
EPS	EUR 2.44
F Score	7
FCF	EUR 2.6B
FCF EV Yield	5.57x
Financing CF	-2,488,667,400
Fiscal Year End	June
Founded	1,916
Graham Number	44.04138
Graham Upside	-39.68
Income Tax	EUR 168.6M
Investing CF	-967,531,200
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Last Split Date	2007-10-18
Last Split Type	Forward
Lynch Fair Value	EUR 12.13
Lynch Upside	-83.39
Ma150	96.49
Ma150ch	-24.34%
Ma20	79.42
Ma20ch	-8.07%
Net CF	-322,794,300
Next Earnings Date	2026-08-18
Open	73.56
P FCF Ratio	13.78
P OCF Ratio	11.66
Payment Date	2026-04-09
Position In Range	0
Ppne	7,898,766,030
Price Date	2026-05-08
Price EBITDA	EUR 8.68
Ptbv Ratio	11.82
Relative Volume	2.67x
Revenue	13,122,141,900x
SBC By Revenue	0.99x
Share Based Comp	129,458,400
Tax By Revenue	1.29x
Tax Rate	12.66%
Tr20y	765.94%
Tr6m	-25.63%
Z Score	4.12

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/CSJ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.4%

$2.47 annual per share

Payout ratio

+101.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.8%

8 consecutive years of growth

Total shareholder yield

+3.3%

Next ex-dividend date: 2026-03-10

Performance

FRA/CSJ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/CSJ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+37.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.1%

Negative means the company is buying back shares.

Technical

FRA/CSJ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.1

Neutral momentum band

Price vs 200-day MA

-30.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-1.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/CSJ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/CSJ stock rating?

fra/CSJ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/CSJ analysis?

The full report lives at /stocks/fra/CSJ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/CSJ?

The latest report frames fra/CSJ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/CSJ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.